Sphingolipids and Cancer: Understanding the Roles of Ceramide and Sphingosine-1-Phosphate in Cell Death and Drug Resistance

Cancer has emerged as the deadliest disease in the world, and researchers are racing to understand its complex mechanisms. Recent studies on sphingolipids have shed light on their role in controlling various aspects of cell growth and proliferation in cancer. Sphingolipids, including ceramide and sphingosine-1-phosphate, have been implicated in the mechanism of action of cancer chemotherapeutics. The metabolism of these lipid molecules has been shown to regulate cell death, drug resistance, and tumor growth. A new study published in Future Oncology has discussed the opposing roles of de novo-generated ceramides and sphingosine-1-phosphate in cancer pathogenesis and the development of sphingolipid-based cancer therapeutics.

Key Takeaways:

• Sphingolipids, including ceramide and sphingosine-1-phosphate, regulate various aspects of cell growth and proliferation in cancer, with ceramide mediating antiproliferative responses and sphingosine-1-phosphate promoting survival, angiogenesis, and metastasis.
• De novo-generated ceramides by ceramide synthases have distinct and opposing roles in the promotion/suppression of tumors, with C(16)-ceramide addiction associated with increased tumor growth and C(18)-ceramide suppressing tumor growth in various cancer models.
• Ceramide metabolism to generate sphingosine-1-phosphate by sphingosine kinases 1 and 2 mediates prosurvival, angiogenesis, metastasis, and/or resistance to drug-induced apoptosis.
• The identification of direct intracellular protein targets of sphingolipids has been key for the development of new chemotherapeutic strategies.
• The researchers concluded that understanding the opposing roles of cerebroid sphingolipid metabolism and sphingosine signaling may lead to the development of new cancer therapeutics and strategies to overcome drug resistance.

Statistics:

• Cancer is becoming the deadliest disease in the world.
• Ceramide synthase 6/C(16)-ceramide addiction was revealed in head and neck cancer cells, associated with increased tumor growth.
• Downregulation of ceramide synthase 6 resulted in ER stress-induced apoptosis.
• Ceramide synthase 1-generated C(18)-ceramide has been shown to suppress tumor growth in various cancer models, both in situ and in vivo.
• Sphingosine-1-phosphate mediates prosurvival, angiogenesis, metastasis, and/or resistance to drug-induced apoptosis.

Sources:

• Ponnusamy, S., et al. (2010). Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncology, 6(10), 1603-24.
• Biotech Week editors (2011). Sphingolipids and cancer: understanding the roles of ceramide and sphingosine-1-phosphate in cell death and drug resistance. Biotech Week via NewsRx.com.